Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0b013e32835d5acdPMID 23269097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases

  2011cited by this paper
• External review and validation of the Swedish national inpatient register

  2011cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of lower gastrointestinal adverse events: a nationwide study in Taiwan

  2011cited by this paper
• Identification of NSAID Users at Risk for Gastrointestinal Complications

  2010cited by this paper
• Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.

  2010cited by this paper
• The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel

  2010cited by this paper
• Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks

  2009cited by this paper
• Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in The Netherlands.

  2009cited by this paper
• Guidelines for Prevention of NSAID-Related Ulcer Complications

  2009cited by this paper
• Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice

  2009cited by this paper
• The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

  2008cited by this paper
• Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents

  2008cited by this paper
• The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

  2007cited by this paper
• Adherence to gastroprotection and the risk of NSAID‐related upper gastrointestinal ulcers and haemorrhage

  2007cited by this paper
• Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.

  2007cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors

  2006cited by this paper
• Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

  2006cited by this paper
• Systematic review: the lower gastrointestinal adverse effects of non‐steroidal anti‐inflammatory drugs

  2006cited by this paper
• Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

  2006cited by this paper
• Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.

  2006cited by this paper
• GI Risk and Risk Factors of NSAIDs

  2006cited by this paper
• National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs.

  2005cited by this paper
• EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

  2004cited by this paper
• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

  2004cited by this paper
• Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

  2003cited by this paper
• Adherence to proton pump inhibitors or H2‐receptor antagonists during the use of non‐steroidal anti‐inflammatory drugs

  2003cited by this paper
• Prevention of NSAID-induced gastroduodenal ulcers.

  2002cited by this paper
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.

  1998cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper
• Drug, Healthcare and Patient Safety Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Prevention of Nsaid-related Upper Gastrointestinal Toxicity: a Meta-analysis of Traditional Nsaids with Gastroprotection and Cox-2 Inhibitors

  year unknowncited by this paper

• Evaluation and Management of a Painful Knee After Total Knee Arthroplasty.

  2021cites this paper
• Histamine H2-Receptor Antagonists Improve Non-Steroidal Anti-Inflammatory Drug-Induced Intestinal Dysbiosis

  2020cites this paper
• Evaluating beneficial drug effects in a non‐interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data

  2017cites this paper
• Construction, internal validation and implementation in a mobile application of a scoring system to predict nonadherence to proton pump inhibitors

  2017influential citation
• Combined Medical Treatment Of Chronic Pancreatitis

  2015cites this paper
• Use of proton pump inhibitors and subsequent risk of celiac disease.

  2014cites this paper
• Prevalence of lesions detected at upper endoscopy: an Italian survey.

  2014cites this paper
• Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs

  2014cites this paper